Hybrid polymeric therapeutic microcarriers for thermoplasmonic-triggered release of resveratrol-Reference-Cited by-同舟云学术

Hybrid polymeric therapeutic microcarriers for thermoplasmonic-triggered release of resveratrol

Published:2022-12 Issue: Volume:220 Page:112915
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Stoia Daria^ORCID,Pop Roxana^ORCID,Campu Andreea^ORCID,Nistor Madalina,Astilean Simion,Pintea Adela^ORCID,Suciu Maria^ORCID,Rugina Dumitrita^ORCID,Focsan Monica^ORCID

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference36 articles.

1. Global estimates of the prevalence of diabetes for 2010 and 2030;Shaw;Diabetes Res. Clin. Pract.,2010

2. Resveratrol-Delivery Vehicle with Anti-VEGF Activity Carried to Human Retinal Pigmented Epithelial Cells Exposed to High-Glucose Induced Conditions;Ruginǎ;Colloids Surf. B: Biointerfaces,2019

3. Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies;Alshaikh;Adv. Drug Deliv. Rev.,2022

4. Use of Biomaterials for Sustained Delivery of Anti-VEGF to Treat Retinal Diseases;Seah;Eye,2020

5. Progress of nanotechnology in diabetic retinopathy treatment;Liu;IJN,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems;Nutrients;2024-05-30

2. Biological Applications of Thermoplasmonics;Nano Letters;2024-01-06

3. Plasmonic structure assisted all-optical tunable fiber laser;Optics Communications;2024-01

4. Albumin nanoparticles with tunable ultraviolet-to-red autofluorescence for label-free cell imaging and selective biosensing of copper ion;International Journal of Biological Macromolecules;2023-07

5. NIR photothermal-activable drug-conjugated microcapsules for in vitro targeted delivery and release: An alternative treatment of diabetic retinopathy;International Journal of Pharmaceutics;2023-03